IRVINE, Calif. (AP) _ Axonics Modulation Technologies Inc. (AXNX) on Thursday reported a loss of $25.1 million in its second quarter.

The Irvine, California-based company said it had a loss of 59 cents per share.

The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 51 cents per share.

The medical technology company posted revenue of $45.9 million in the period, beating Street forecasts. Four analysts surveyed by Zacks expected $39.2 million.

Axonics expects full-year revenue in the range of $186 million to $188 million.

Axonics shares have increased 26% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $63.01, a climb of 42% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AXNX at https://www.zacks.com/ap/AXNX

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News